Filter posts

A National Blueprint for Biodefense Released Today

A major report was released today detailing findings and recommendations to improve the U.S. biodefense …

Biotech Policy Outlook at #BIF15: 21st Century Cures, IPR, TPP, and PDUFA VI

To even the most casual observer, 2015 has been a big year in the biotech …

PTAB Ruling Proves Medical Innovation Under Attack

There’s more evidence today that the IPR system needs to be fixed. PTAB ruled on …

BIO on CNBC: IPR System Weakens Medical Innovation

Last night Ron Cohen, M.D., CEO of Acorda Therapeutics and BIO’s board chair, appeared on …

Here are the Facts about the IPR Kill Rate

FiercePhrma recently ran an article repeating a dubious analysis of the crisis caused by the …

102 Organizations Urge Congress to Maintain a Strong Patent System and Protect Innovation

A diverse group of more than 100 national and state-based advocacy organizations have united to …

Congress Blog: Medical Advances Keep Me Running

This week, 74-year-old multiple myeloma patient Don Wright shares his story on how cancer drugs have …

Register for the 2015 BIO IP & Diagnostics Symposium!

The Third Annual BIO IP & Diagnostics Symposium takes place on September 18, 2015 in Alexandria, …

WSJ: U.S. Concessions on TPP Means Fewer Cures

Today’s Wall Street Journal editorial, Pacific Trade Brinksmanship, does an outstanding job highlighting the important …

New Report Suggests RDP Does Not Increase Healthcare Expenditures

A new paper by the Geneva Network suggests that increasing the period of regulatory data …